Can innate immune system targets turn up the heat on 'cold' tumours?

Nature Reviews Drug Discovery 17, 3 (2018). doi:10.1038/nrd.2017.264 Author: Asher Mullard STING, RIG-I and NLRP3 agonists might increase the effectiveness of immuno-oncology checkpoint inhibitors, while antagonists of these targets offer an anti-inflammatory bonus.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research